JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKKβ

Zilu Zhang; Chenjing Ye; Jia Liu; Wenbin Xu; Chao Wu; Qing Yu; Xiaoguang Xu; Xinyi Zeng; Huizi Jin; Yingli Wu; Hua Yan

doi:10.20892/j.issn.2095-3941.2020.0473

Article Information

vol. 19 no. 5 651-668

DOI

https://doi.org/10.20892/j.issn.2095-3941.2020.0473

PubMed

34570444

Published By

Cancer Biology & Medicine

History

Received August 15, 2020
Accepted March 10, 2021
Published online June 24, 2022.

Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

Zilu Zhang1,*,
Chenjing Ye2,*,
Jia Liu1,
Wenbin Xu2,
Chao Wu2,
Qing Yu2,
Xiaoguang Xu1,
Xinyi Zeng1,
Huizi Jin3,
Yingli Wu4 ⇑ and
Hua Yan1,2 ⇑

¹Shanghai Institute of Hematology, Affiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
²VIP Health Center, Affiliated Ruijin Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
³Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China
⁴Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Basic Medicine, Chemical Biology Division of Shanghai Universities E-Institutes, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China